Thermo Fisher Scientific (TMO) filed a registration statement Monday with the US Securities and Exchange Commission for the potential sale of securities from time to time in one or more offerings.
The filing covers debt securities, common stock, preferred stock, depositary shares, purchase contracts, units,
warrants, and guarantees, and includes the potential offering of debt securities by Thermo Fisher Scientific B.V.
Net proceeds will be used for general corporate purposes, which may include acquisitions, debt repayment and refinancing, working capital and capital expenditures or the repurchase of shares, the company said.
TMO shares were 1.6% higher in recent trading.
Price: 541.16, Change: +8.61, Percent Change: +1.62
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。